会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHOD OF CANCER TREATMENT WITH NAPHTHOL ANALOGS
    • 用萘酚类似物治疗癌症的方法
    • WO2008106248A1
    • 2008-09-04
    • PCT/US2008/051398
    • 2008-01-18
    • BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMKOO, Ja, SeokBORNMANN, WilliamMAXWELL, David
    • KOO, Ja, SeokBORNMANN, WilliamMAXWELL, David
    • A61K31/661A61P35/00A61P35/02
    • A61K31/661
    • In one embodiment, the present invention relates to a method of treating a cancer characterized by overexpression of cyclic adenosine monophosphate response element-binding protein (CREB) or phosphorylated CREB (p-CREB) by administering to a patient suffering from the cancer a pharmaceutically-effective amount of a composition comprising a compound selected from the group consisting of 2-{1-[3-(Amidinothio)propyl]-1H-indol-3-yl}-3-(1-methylindol-3-yl)maleimide, naphthol analogs having the structure (I), wherein R 1 is selected from the group consisting of -H, -F, -Cl, -Br, and -I; R 2 is selected from the group consisting of -H, -F, -Cl, -Br, -I, -C 1-6 alkyl, -C 1-6 alkenyl, and -C 1-6 alkynyl; R 3 is selected from the group consisting of -H and -NO 2 ; and R 4 is selected from the group consisting of -H, -C 1-6 alkyl, -C 1-6 alkenyl, -C 1-6 alkynyl, -OC 1-6 alkyl, -OC 1-6 alkenyl, and -OC 1-6 alkynyl; and salts and esters thereof.
    • 在一个实施方案中,本发明涉及一种治疗癌症的方法,其特征在于通过向患有癌症的患者施用药学上可接受的方法来过表达环腺苷一磷酸应答元件结合蛋白(CREB)或磷酸化CREB(p-CREB) 有效量的包含选自2- {1- [3-(脒基硫代)丙基] -1H-吲哚-3-基} -3-(1-甲基吲哚-3-基)马来酰亚胺的化合物的组合物, 具有结构(I)的萘酚类似物,其中R 1选自-H,-F,-Cl,-Br和-I; R 2选自-H,-F,-Cl,-Br,-I,-C 1-6 - 烷基,-C 1-6个烯基和-C 1-6个炔基; R 3选自-H和-NO 2 2; 和R 4选自-H,-C 1-6 - 烷基,-C 1-6 - 烯基,-C 1-6烷基,-OC 1-6烯基和-OC 1-6亚烷基,-OC 1-6, 炔基; 及其盐和酯。
    • 6. 发明申请
    • USES OF HUMAN PEPTIDE DEFORMYLASE
    • 使用人类胃蛋白酶
    • WO2005044995A2
    • 2005-05-19
    • PCT/US2004036866
    • 2004-11-04
    • SLOAN KETTERING INST CANCERSCHEINBERG DAVID ALEE MONA DSIROTNAK FRANCIS MANTCZAK CHRISTOPHEBORNMANN WILLIAM G
    • SCHEINBERG DAVID ALEE MONA DSIROTNAK FRANCIS MANTCZAK CHRISTOPHEBORNMANN WILLIAM G
    • C12N20060101C12N
    • C12N9/80A61K38/00C12N15/1137C12N2310/14C12Y305/01088
    • This invention provides a substance derived naturally or manufactured through chemical or genetic engineering that is capable of inhibiting the removal of N-formyl group from peptides by peptide deformylase. This invention also provides a nucleic acid molecule encoding the above fragment of human peptide deformylase or its functional equivalent. This invention provides methods of identifying (1) a compound that inhibits peptide deformylase or its functional equivalent, and (2) a compound that inhibits tumor growth. The invention further provides a method of identifying a compound that inhibits tumor growth comprising comparison of the inhibitory concentration or binding affinity of the compound to a bacterial peptide deformylase with a human peptide deformylase, and this inhibitory concentration or binding of the compound to human peptide deformylase indicates a better inhibition of tumor growth. This invention provides a composition comprising an effective amount of the compound identified by the above methods and a suitable carrier.
    • 本发明提供了一种天然产生的或通过化学或遗传工程制造的物质,其能够通过肽去甲酰化酶抑制从肽中去除N-甲酰基。 本发明还提供了编码人肽脱甲酰酶的上述片段或其功能等同物的核酸分子。 本发明提供鉴定(1)抑制肽脱甲酰酶或其功能等价物的化合物的方法,和(2)抑制肿瘤生长的化合物。 本发明还提供了鉴定抑制肿瘤生长的化合物的方法,其包括将化合物与细菌肽变性酶与人肽脱甲酰酶的抑制浓度或结合亲和性与人肽变性酶的抑制浓度或结合作用 表明更好地抑制肿瘤生长。 本发明提供了包含有效量的通过上述方法鉴定的化合物和合适的载体的组合物。